
Vali oma silt
näidatakse otse viaalilReta + Cagri Blend
GLP-1
- Saadetakse Saksamaalt
Tellimus
- DHL koos jälgimisega
- Diskreetne pakend
Lühidalt
Reta + Cagri Blend arvudes
Põhinäitajad meie leksikonist.
Täielik leksikoni artikkel- Class
- Triple agonistGLP-1 / GIP / glucagon, + amylin analog
- Half-life
- Retatrutide around 6 dayscagrilintide around 7 to 8 days
- Form
- Lyophilisatepowder, reconstituted with BAC water
- Sizes
- 30 mg1 size in the shop
What studies show
All 5 sources in the lexicon- up to24.2 %Jastreboff et al., NEJM, 2023
- Sanyal et al., Nature Medicine, 2024
- Lau et al., The Lancet, 2021
Arvustused
Mida kliendid ütlevad
Ainult päris tellimused, milles oli Reta + Cagri Blend.
Kõik arvustusedReta + Cagri Blend jaoks pole veel laborianalüüsi. Hääleta selle pooltLase ise testida, meie maksame pooleKõik laborianalüüsid
Teadmised
Kõik teemal Reta + Cagri Blend
Üksikasjalik teave tuleb peagi.
Annustamine
Annustamisteabe laadimine …
Telli kohe kaasa
Mida sul sellega vaja on
Bakteriostaatiline vesi lisatakse ostukorvi automaatselt. Süstlad ja lapid ühe klõpsuga.
Insuliinisüstlad
10 tk · 5.50 €
Alkoholilapid
50 tk · 10 €
Kui palju vett?
Ühikud süstlal sinu viaali suuruse jaoks.
Ava kalkulaator →Is the Reta + Cagri Blend approved or studied?
No. As of 26 October 2026 the registry ClinicalTrials.gov lists no trial with Retatrutide and cagrilintide together. Both components are in phase 3 and not approved.
Why Retatrutide and cagrilintide together?
Both act on different satiety pathways: Retatrutide on GLP-1, GIP and glucagon, cagrilintide on amylin receptors. With semaglutide as the partner, weight loss in a phase 1b trial after 20 weeks was 17.1 instead of 9.8 percent. For Retatrutide as the partner there are no data.
What do the studies of the components show?
Retatrutide alone: in TRIUMPH-1 after 80 weeks 25.0 percent less body weight on average at the highest study dose, 3.9 percent on placebo. Cagrilintide alone: up to 10.8 percent after 26 weeks in phase 2, 3.0 percent on placebo. In a substudy liver fat also fell sharply on Retatrutide.
Why is the cagrilintide share so small?
The vial contains five times as much Retatrutide as cagrilintide, because Retatrutide is the stronger and limiting part. Anyone going by the Retatrutide share stays far below the amounts used in the cagrilintide trials. Whether the small share contributes anything has not been studied.
How long do the components stay in the body?
Retatrutide had a half-life of about six days in a phase 1b study, cagrilintide 159 to 195 hours in another study, so about a week. Both fit one dose per week.
Which side effects were seen with the components?
With both, mainly gastrointestinal effects such as nausea and diarrhoea, depending on the dose. On Retatrutide heart rate rose in a dose-dependent way in phase 2. Two satiety signals together may strengthen nausea at the start, this has not been measured for this blend.
Which trials are still running?
Nine phase 3 trials of Retatrutide are running, the largest on heart and kidney events until 2029. The RENEW trials of cagrilintide alone run until 2027. No trial of the blend is listed in the registry.
Seotud
Seotud tooted
Tirzepatide
Peptiidid · GLP-1 ja rasvapõletus GLP-1 ja rasvapõletus
10 suurust
Laboris testitud
= alates 10 €/viaal
Retatrutide
Peptiidid · GLP-1 ja rasvapõletus GLP-1 ja rasvapõletus
11 suurust
Laboris testitud
= alates 16 €/viaal
Semaglutide
Peptiidid · GLP-1 ja rasvapõletus GLP-1 ja rasvapõletus
6 suurust
Laboris testitud
= alates 10 €/viaal
Mazdutide
Peptiidid · GLP-1 ja rasvapõletus GLP-1 ja rasvapõletus
2 suurust
= alates 32 €/viaal
Reta + Cagri Blend